证券研究报告行业周度点评医疗器械第四批高值耗材国采2号文发布，整体规则温和2023年11月20日重点股票2022A2023E2024E评级评级领先大市EPS（元）PE（倍）EPS（元）PE（倍）EPS（元）PE（倍）买入买入迈瑞医疗6.5843.398.0535.479.7629.25增持22.42增持评级变动：维持心脉医疗4.9638.656.5629.238.5535.87增持13.51增持惠泰医疗5.3766.267.3748.289.9228.48增持29.16增持行业涨跌幅比较鱼跃医疗1.5918.871.9915.082.2263.67增持31.97医疗器械沪深300我武生物0.6743.780.8235.771.0322.592023-022023-052023-082023-1116%诺唯赞1.4923.880.7348.741.226%-4%澳华内镜0.16413.880.65101.881.04-14%-24%开立医疗0.8655.761.1541.701.52022-11海泰新光2.127.861.9530.002.59资料来源：iFinD，财信证券%1M3M12M投资要点：...